These findings that mHLA‐DR+ and PD‐1 + CD4‐CD8‐T predict mortality risk early in the course of sepsis may contribute to improved models of sepsis‐related immune dysregulation, risk‐stratification, and personalized treatment strategies. The gene discussed is CD8A; the disease is Sepsis.